New York, November 9, 2026 / PRNewswire / -- Investment firm focused on driving healthcare development, Deerfield Management, announced today a partnership with Amazon Web Services, AWS, aimed at accelerating the development and scaling of AI native healthcare and life science companies.
According to the announcement, this collaboration will combine the generative AI of AWS, the engineering teams for cloud services and AI of Deerfield Intelligence, as well as the innovative ecosystem of the company's affiliated institution Cure. The goal is to assist some selected Deerfield investee companies in deploying agent-based AI systems in areas such as drug discovery, operational automation, and care delivery. In addition to the application by the investee companies, both parties also plan to enhance Deerfield's own capabilities by integrating AWS's AI services into the companies' research, evaluation, and operational processes.
As part of this expanded partnership, AWS will be designated as the preferred AI supplier for Deerfield and some of its invested companies. The announcement states that the Deerfield Intelligence, Deerfield Discovery, and, and Development (3DC) teams under Deerfield will receive AWS's AI and cloud technology, as well as technical support, to expand their proprietary medical AI products and promote AI capabilities among invested companies interested in Deerfield. Some of the Deerfield invested companies will also receive AWS's AI and cloud technology, along with technical empowerment and training, including large-scale model training, inference optimization, and managed services tailored for the medical industry.
"This collaboration is aimed at promoting the development of the next generation of AI driver-based medical organizations," said Dan Sheeran, Vice President and General Manager of AWS for Healthcare and Life Sciences. "With the support of AWS, interested Deerfield investee companies can access AI services specifically tailored to meet the needs of healthcare and life sciences, such as Amazon Bio Discovery, as well as proxy services like Amazon Bedrock AgentCore for building AI proxies, enabling support for related organizations on a scale that was previously unattainable just a few years ago."
Managing Partner Jim Flynn stated: “Deerfield is committed to building an ambitious AI native platform in the healthcare sector. Our Intelligence team is developing models with the goal of transforming how we identify opportunities, evaluate scientific projects, and accelerate the growth of the companies we invest in. With the help of AWS’s healthcare services, we aim to help companies speed up the development process when building their own clinical solutions.”
The announcement states that this collaboration is built upon the early progress of the Deerfield investment portfolio. Ascertain, a medical technology company supported by Deerfield, is utilizing AWS services in its agent-based AI platform. This platform can automate complex clinical and administrative workflows, such as case management and pre-authorization, rather than merely making incremental improvements to traditional processes.
"We founded Ascertain to free up clinicians' time by automating administrative tasks in nursing; we believe that the services tailored for the healthcare industry by AWS will help us enhance these capabilities," said Deerfield's Chief Information Officer and Ascertain's Chief Executive Officer, Dr. Mark Michalski. "We consider the collaboration between Deerfield and AWS, as well as the AI and cloud services they provide to Ascertain and other invested companies, to be a fundamental component that has the potential to enable large-scale implementation of a AI-driven transformation."
The announcement states that the collaboration with AWS is also built upon Deerfield's long-standing support for companies in the healthcare industry. Deerfield is headquartered in the Cure medical innovation park in New York City, located at the heart of one of the world's most densely populated healthcare ecosystems. The area is surrounded by leading academic medical centers, a rapidly growing biotechnology industry, and a wide network of clinicians and investors. Deerfield's team consists of over 190 professionals, including more than 60 doctors of medicine, law, and philosophy. Looking to the future, Deerfield and AWS plan to jointly organize project activities in Cure, aiming to transform this space into a shared hub for the healthcare innovation community.
About Deerfield Management
Deerfield is an investment management company dedicated to promoting the healthy development of healthcare through investment, intelligent capabilities, and philanthropic efforts. The headquarters of the Deerfield ecosystem are located in the New York City Medical Innovation Park Cure. This ecosystem includes the company's internal R&D engines Deerfield Discovery, and, Development (3DC), as well as its data, technology, and artificial intelligence departments Deerfield Intelligence. Deerfield indicates that the company collaborates within the entire healthcare ecosystem to connect talents, capital, creativity, and technology in a bold, collaborative, and inclusive manner. For more information, please visit: www.deerfield.com.
Contact Person:Jessica Sagers, PhD, person in charge of dissemination, jsagers @ deerfield.com
